Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

TBIO

Telesis Bio Inc

Apr 18 • 04:00PM ET

0.3310

Dollar change -0.0490
Percentage change -12.89	%

Healthcare • Medical Devices • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.64	Insider Own	70.83%	Shs Outstand	30.06M	Perf Week	-24.12%
Market Cap	9.96M	Forward P/E	-	EPS next Y	-0.58	Insider Trans	0.00%	Shs Float	8.78M	Perf Month	-38.59%
Income	-49.02M	PEG	-	EPS next Q	-0.23	Inst Own	5.53%	Short Float	1.14%	Perf Quarter	5.78%
Sales	27.51M	P/S	0.36	EPS this Y	52.44%	Inst Trans	-12.74%	Short Ratio	0.13	Perf Half Y	-65.16%
Book/sh	0.01	P/B	41.79	EPS next Y	25.64%	ROA	-62.89%	Short Interest	0.10M	Perf Year	-88.89%
Cash/sh	0.64	P/C	0.52	EPS next 5Y	-	ROE	-125.42%	52W Range	0.30 - 3.01	Perf YTD	-17.04%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-55.07%	ROI	-78.95%	52W High	-89.00%	Beta	1.91
Dividend TTM	-	Quick Ratio	3.22	Sales past 5Y	63.37%	Gross Margin	53.39%	52W Low	10.33%	ATR (14)	0.06
Dividend Ex-Date	-	Current Ratio	3.71	EPS Y/Y TTM	0.32%	Oper. Margin	-127.78%	RSI (14)	31.70	Volatility	20.29% 14.35%
Employees	147	Debt/Eq	1.16	Sales Y/Y TTM	0.27%	Profit Margin	-178.21%	Recom	1.67	Target Price	4.00
Option/Short	Yes / Yes	LT Debt/Eq	1.10	EPS Q/Q	-121.26%	Payout	-	Rel Volume	0.33	Prev Close	0.38
Sales Surprise	-0.33%	EPS Surprise	-154.17%	Sales Q/Q	-26.32%	Earnings	Mar 28 AMC	Avg Volume	760.90K	Price	0.33
SMA20	-23.49%	SMA50	-26.83%	SMA200	-57.29%	Trades		Volume	253,893	Change	-12.89%

Today 09:00AM	Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership (GlobeNewswire) -12.89%
Mar-28-24 11:53PM	TBIO Stock Earnings: Telesis Bio Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
04:25PM	Telesis Bio: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-26-24 09:15AM	Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results (GlobeNewswire) -15.38%
08:44AM	Loading…
Feb-23-24 08:44AM	Why Is Telesis Bio (TBIO) Stock Up 29% Today? (InvestorPlace) +70.27%
Nov-13-23 05:32PM	Telesis Bio: Q3 Earnings Snapshot (Associated Press Finance) -5.27%
04:22PM	Telesis Bio Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-07-23 09:00AM	Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023 (GlobeNewswire)
Nov-03-23 12:00PM	Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA (GlobeNewswire) +6.67%
Sep-28-23 03:48PM	Telesis Bio Announces Commercial Release of BioXp NGS Library Prep Kit for WGS (GlobeNewswire)
Aug-29-23 04:05PM	Telesis Bio Appoints William J. Kullback Chief Financial Officer (GlobeNewswire)
Aug-10-23 04:51PM	Telesis Bio: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Telesis Bio Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-03-23 05:00PM	Telesis Bio to Report Second Quarter Financial Results on Thursday, August 10, 2023 (GlobeNewswire) -5.44%
09:05AM	Loading…
Jun-08-23 09:05AM	Telesis Bio to Present at Jefferies Healthcare Conference 2023 (GlobeNewswire)
Jun-06-23 03:00AM	Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023 (GlobeNewswire)
Jun-05-23 05:30PM	Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock (GlobeNewswire) -6.07%
May-31-23 05:29PM	Telesis Bio Secures Financing of $28.0 Million (GlobeNewswire)
May-23-23 09:00AM	Telesis Bio to Present at SynBioBeta 2023 (GlobeNewswire)
May-22-23 12:00PM	Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit (GlobeNewswire)
May-18-23 10:00AM	Telesis Bio Announces First Commercial Shipment of BioXp® NGS Library Prep Kit (GlobeNewswire)
May-15-23 09:00AM	Telesis Bio to Present at Protein Engineering Summit (PEGS Boston 2023) (GlobeNewswire) -9.49%
May-13-23 08:05AM	Telesis Bio First Quarter 2023 Earnings: EPS Beats Expectations, Revenues Lag (Simply Wall St.)
May-12-23 04:17PM	Blue Bird, First Solar rise; Harrow Health, Telesis Bio fall (AP Finance) -12.15%
May-11-23 05:25PM	Telesis Bio (TBIO) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:22PM	Telesis Bio: Q1 Earnings Snapshot (AP Finance)
04:05PM	Telesis Bio Reports First Quarter 2023 Financial Results (GlobeNewswire)
Apr-27-23 04:05PM	Telesis Bio to Report First Quarter Financial Results on Thursday, May 11, 2023 (GlobeNewswire)
Apr-17-23 07:50AM	Beat the Market the Zacks Way: Hershey's, Telesis Bio, General Mills in Focus (Zacks)
06:47AM	Loading…
06:47AM	Telesis Bio, Inc.'s (NASDAQ:TBIO) Shares Leap 38% Yet They're Still Not Telling The Full Story (Simply Wall St.)
Mar-31-23 09:00AM	Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up (GlobeNewswire) +5.08%
Mar-28-23 04:59AM	Telesis Bio, Inc. (NASDAQ:TBIO) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-25-23 08:21AM	Telesis Bio, Inc.'s (NASDAQ:TBIO) Shift From Loss To Profit (Simply Wall St.)
Mar-21-23 05:25PM	Telesis Bio (TBIO) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +5.74%
04:05PM	Telesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance (GlobeNewswire)
Mar-16-23 06:00AM	Telesis Bio to Present at Festival of Biologics Conference (GlobeNewswire)
Mar-14-23 06:00AM	Telesis Bio to Present at RNA Leaders Europe Congress (GlobeNewswire) +8.26%
Mar-09-23 04:30PM	Telesis Bio to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, March 21, 2023 (GlobeNewswire) +9.21%
Feb-27-23 09:00AM	Telesis Bio to Present at the Cowen 43rd Annual Healthcare Conference (GlobeNewswire) +6.75%
Feb-16-23 09:00AM	Telesis Bio Releases BioXp® Select mRNA Synthesis Kit to Expand the Utility, Speed, and Impact of Its Automated Synthetic Biology Workstation (GlobeNewswire) +7.10%
Jan-09-23 09:00AM	Telesis Bio Pre-Announces Preliminary Fourth Quarter Financial Results (GlobeNewswire) +11.49%

Telesis Bio, Inc. engages in the provision of automated multi-omic and synthetic biology solutions. The firm also focuses on providing applications to enable researchers to rapidly, accurately, and reproducibly build or write synthetic DNA and mRNA and short oligonucleotides such as CRISPR guides that are ready to use in many downstream synthetic biology enabled markets. The company was founded by Daniel G. Gibson and J. Craig Venter on March 24, 2011 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Nelson Todd Robert	President & CEO	May 04 '23	Sale	2.83	2,575	7,277	136,072	May 08 08:11 PM
Gibson Daniel Glenn	Chief Technology Officer	May 04 '23	Sale	2.83	1,190	3,363	102,083	May 08 08:09 PM
Cutler Rob	Chief Legal Officer	May 04 '23	Sale	2.83	1,174	3,318	25,468	May 08 08:06 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TBIO

Telesis Bio Inc

Upgrade your FINVIZ experience